Market Cap 47.97M
Revenue (ttm) 0.00
Net Income (ttm) -37.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.81
Volume 633,200
Avg Vol 482,084
Day's Range N/A - N/A
Shares Out 47.03M
Stochastic %K 19%
Beta 1.11
Analysts Strong Sell
Price Target $7.50

Company Profile

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company's lead product candidate is Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T c...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 208 3343
Address:
303A College Road East, Princeton, United States
Ontherag
Ontherag Oct. 5 at 2:47 AM
$PDSB Thanks captain obvious. We have been trading in the 1 dollar range for a while now.
1 · Reply
alphabetsop
alphabetsop Oct. 4 at 6:20 PM
$PDSB As far as ESMO Congress, any mention would be great but maybe nothing lines up timing wise. I see several mentioning tax loss harvesting and it will hurt us. I don't see how the stock price can withstand another round of that in the upcoming weeks. Once it trades for nickels that will leave the company with no recourse but to execute on the most toxic never ending spiral financing. It's worrisome to say the least.
0 · Reply
alphabetsop
alphabetsop Oct. 4 at 12:32 AM
$PDSB no appearance at the upcoming ESMO Congress a la last year is a terrible sign IMO.
1 · Reply
NotBornYesterday
NotBornYesterday Oct. 3 at 2:57 PM
$PDSB 🫰 🫰
0 · Reply
SMARTR8
SMARTR8 Oct. 3 at 2:47 PM
$PDSB another sleeper like $BTMD 👀
0 · Reply
NotBornYesterday
NotBornYesterday Oct. 3 at 12:08 PM
$PDSB Next comes tax loss harvesting season.
1 · Reply
Mr_Charlie
Mr_Charlie Oct. 2 at 4:05 PM
$PDSB seeing this "gold" mine stock price dropping every week might be getting some folks blind!!
0 · Reply
dvice2
dvice2 Oct. 2 at 2:41 PM
$PDSB not much detail here but heres a new preprint abstract with R-DOTAP being used with Flublok. https://www.biorxiv.org/content/10.1101/2025.10.01.678836v1
1 · Reply
Ontherag
Ontherag Oct. 2 at 12:47 AM
$PDSB https://www.prnewswire.com/news-releases/hpv-positive-oropharyngeal-cancer-market-poised-for-strong-growth-by-2034-driven-by-rising-incidence-and-treatment-innovation--delveinsight-302570564.html
0 · Reply
lookgoodplaygood22
lookgoodplaygood22 Oct. 1 at 3:48 PM
0 · Reply
Latest News on PDSB
PDS Biotech Leadership to Participate in March Conferences

Mar 11, 2025, 8:00 AM EDT - 7 months ago

PDS Biotech Leadership to Participate in March Conferences


PDS Biotechnology: Continuing The Holding Pattern

Sep 23, 2024, 10:39 AM EDT - 1 year ago

PDS Biotechnology: Continuing The Holding Pattern


PDS Biotechnology Announces Details of Virtual KOL Event

May 3, 2024, 8:00 AM EDT - 1 year ago

PDS Biotechnology Announces Details of Virtual KOL Event


Ontherag
Ontherag Oct. 5 at 2:47 AM
$PDSB Thanks captain obvious. We have been trading in the 1 dollar range for a while now.
1 · Reply
alphabetsop
alphabetsop Oct. 4 at 6:20 PM
$PDSB As far as ESMO Congress, any mention would be great but maybe nothing lines up timing wise. I see several mentioning tax loss harvesting and it will hurt us. I don't see how the stock price can withstand another round of that in the upcoming weeks. Once it trades for nickels that will leave the company with no recourse but to execute on the most toxic never ending spiral financing. It's worrisome to say the least.
0 · Reply
alphabetsop
alphabetsop Oct. 4 at 12:32 AM
$PDSB no appearance at the upcoming ESMO Congress a la last year is a terrible sign IMO.
1 · Reply
NotBornYesterday
NotBornYesterday Oct. 3 at 2:57 PM
$PDSB 🫰 🫰
0 · Reply
SMARTR8
SMARTR8 Oct. 3 at 2:47 PM
$PDSB another sleeper like $BTMD 👀
0 · Reply
NotBornYesterday
NotBornYesterday Oct. 3 at 12:08 PM
$PDSB Next comes tax loss harvesting season.
1 · Reply
Mr_Charlie
Mr_Charlie Oct. 2 at 4:05 PM
$PDSB seeing this "gold" mine stock price dropping every week might be getting some folks blind!!
0 · Reply
dvice2
dvice2 Oct. 2 at 2:41 PM
$PDSB not much detail here but heres a new preprint abstract with R-DOTAP being used with Flublok. https://www.biorxiv.org/content/10.1101/2025.10.01.678836v1
1 · Reply
Ontherag
Ontherag Oct. 2 at 12:47 AM
$PDSB https://www.prnewswire.com/news-releases/hpv-positive-oropharyngeal-cancer-market-poised-for-strong-growth-by-2034-driven-by-rising-incidence-and-treatment-innovation--delveinsight-302570564.html
0 · Reply
lookgoodplaygood22
lookgoodplaygood22 Oct. 1 at 3:48 PM
0 · Reply
CalculatedSwing
CalculatedSwing Oct. 1 at 3:03 PM
$GLMD 🚀 $GLMD soaring +10% on epic proxy news! CEO Baharaff locked in with equity grants & performance bonuses tied to big milestones—NASH pipeline looking hot! Newbies, this is your chance to go all in for the moon! 🌕 Tagging the degens, leg up time: $SGMT $GTBP $PDSB $GNPX #Biotech #AllIn
1 · Reply
Mr_Charlie
Mr_Charlie Oct. 1 at 2:02 PM
$PDSB I have little faith here. When market values this company at less than 50M then something is wrong. Probably nobody believes ph2 clinical trial results. And has happened before, many times, they come out saying that they got wonderful results, and then ph3 is a no no, the expected main objective was not achieved. I will not be surprised.
0 · Reply
DesertDweller93
DesertDweller93 Oct. 1 at 1:33 PM
WOW, $PDSB actually added 5 sites to their phase 3 trial. Only took about 8 months to get to 18 sites. Frank please either step down or sell the company. Do your investors a favor. https://clinicaltrials.gov/study/NCT06790966?intr=PDS0101&rank=3&a=9&b=10&compareMode=sideBySide#contacts-and-locations
1 · Reply
highnihilism
highnihilism Oct. 1 at 12:06 PM
$PFS Provident Financial Services Trades: 5 | Total $: 476 | 0.32 × 90-Day Avg $: 1.5 K | Call $: 476 | Put $: 0 | Single-Leg: 9% | Multi-Leg: 91% | Contingent: – $XYZY Tidal Trust II $XYZ Option Income Strategy ETF Trades: 16 | Total $: 80.1 K | 18.09 × 90-Day Avg $: 4.4 K | Call $: 475 | Put $: 79.6 K | Single-Leg: 57% | Multi-Leg: 43% | Contingent: – $PDSB PDS Biotechnology Trades: 4 | Total $: 3.5 K | 1.66 × 90-Day Avg $: 2.1 K | Call $: 470 | Put $: 3 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $GWRS Global Water Resources Trades: 4 | Total $: 514 | 0.15 × 90-Day Avg $: 3.3 K | Call $: 470 | Put $: 44 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
AmazingStockBuyer
AmazingStockBuyer Oct. 1 at 8:45 AM
0 · Reply
alphabetsop
alphabetsop Sep. 30 at 11:04 PM
$PDSB another know it all biotechdruganalyst starting posting on X. out of the blue annoying. I always wonder how many of these folks who post assertively on X are cowards in real life and only thrive as an unknown on social media.
0 · Reply
alphabetsop
alphabetsop Sep. 30 at 10:55 PM
$PDSB keeping it pinned to $1 right now. Hopefully this precedes news of a deal of some sort. If it breaks $.95 support there will be a world of pain
0 · Reply
SMARTR8
SMARTR8 Sep. 30 at 10:51 PM
$PDSB added some.
0 · Reply
bmess
bmess Sep. 30 at 7:08 PM
$PDSB unfortunately no offer.
0 · Reply
Fishman2001
Fishman2001 Sep. 30 at 6:38 PM
$PDSB Frank take the offer, for five years you referenced potential partnerships, it’s time.
1 · Reply
Mr_Charlie
Mr_Charlie Sep. 30 at 1:25 PM
$PDSB PDSB Probability of Bankruptcy The Probability of Bankruptcy of PDS Biotechnology Corp (PDSB) is 58.7% . This number represents the probability that PDSB will face financial distress in the next 24 months given its current fundamentals and market conditions. Multiple factors are taken into account when calculating PDSB's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
1 · Reply
Mr_Charlie
Mr_Charlie Sep. 30 at 1:13 PM
$PDSB I am definitely not dropping more money on this one.
0 · Reply